A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Prevention Research

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1940-6207.CAPR-10-0193PMID 21372037PMCID PMC3057372
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens

  2011influential reference
• Assessing Lead Time of Selected Ovarian Cancer Biomarkers: A Nested Case–Control Study

  2010cited by this paper
• Sources of bias in specimens for research about molecular markers for cancer.

  2010cited by this paper
• A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.

  2009cited by this paper
• Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design

  2008cited by this paper
• Systematic Evaluation of Candidate Blood Markers for Detecting Ovarian Cancer

  2008cited by this paper
• National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.

  2008cited by this paper
• Diagnostic Markers for Early Detection of Ovarian Cancer

  2008cited by this paper
• National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements.

  2008cited by this paper
• Early detection of ovarian cancer.

  2008cited by this paper
• Early Detection of Ovarian Cancer

  2007cited by this paper
• Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer.

  2007cited by this paper
• Effects of Blood Collection Conditions on Ovarian Cancer Serum Markers

  2007cited by this paper
• Evaluating markers for the early detection of cancer: overview of study designs and methods

  2006cited by this paper
• Evaluation of Apolipoprotein A1 and Posttranslationally Modified Forms of Transthyretin as Biomarkers for Ovarian Cancer Detection in an Independent Study Population

  2006cited by this paper
• Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial.

  2005cited by this paper
• Serum protein markers for early detection of ovarian cancer.

  2005cited by this paper
• Bias as a threat to the validity of cancer molecular-marker research

  2005cited by this paper
• Multiplexed Immunobead-Based Cytokine Profiling for Early Detection of Ovarian Cancer

  2005influential reference
• Epidemiology informing clinical practice: from bills of mortality to population laboratories

  2005cited by this paper
• Proteomic patterns to identify ovarian cancer: 3 years on

  2004cited by this paper
• Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

  2004cited by this paper
• Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

  2004cited by this paper
• Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.

  2003cited by this paper
• Translation of highly promising basic science research into clinical applications.

  2003cited by this paper
• Use of proteomic patterns in serum to identify ovarian cancer.

  2002cited by this paper
• Phases of biomarker development for early detection of cancer.

  2001cited by this paper
• Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial.

  2000cited by this paper
• Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

  2000cited by this paper
• The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.

  2000cited by this paper
• Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

  1988cited by this paper

• Modular DNA nanosensors enable state-aware multiplexed single-molecule mass photometry in complex media

  2026cites this paper
• A Prospective Study Consortium for the Discovery and Validation of Early Detection Markers for Ovarian Cancer ("PREDICT") - Baseline findings for CA125.

  2025cites this paper
• Framework to Select Multi-Cancer Detection Assays in the National Cancer Institute’s Vanguard Study

  2025cites this paper
• Evaluating a blood test for Colon cancer screening: how simulation modeling can inform clinical policy making and research.

  2024cites this paper
• A candidate panel of eight urinary proteins shows potential of early diagnosis and risk assessment for diabetic kidney disease in type 1 diabetes.

  2024cites this paper
• Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies.

  2024cites this paper
• 5-Hydroxymethylated Biomarkers in Cell-Free DNA Predict Occult Colorectal Cancer up to 36 Months Before Diagnosis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

  2024cites this paper
• Bayesian and deep‐learning models applied to the early detection of ovarian cancer using multiple longitudinal biomarkers

  2024cites this paper
• Machine Learning Identifies a Signature of Nine Exosomal RNAs That Predicts Hepatocellular Carcinoma

  2023cites this paper
• Chewing the fat: How lipidomics is changing our understanding of human health and disease in 2022

  2023cites this paper
• A Boolean-based machine learning framework identifies predictive biomarkers of HSP90-targeted therapy response in prostate cancer

  2023cites this paper
• Current and emerging biomarkers in ovarian cancer diagnosis; CA125 and beyond.

  2023cites this paper
• Estimating stage-specific sensitivity for cancer screening tests

  2023cites this paper
• Tasks and Experiences of the Prospective, Longitudinal, Multicenter MoMar (Molecular Markers) Study for the Early Detection of Mesothelioma in Individuals Formerly Exposed to Asbestos Using Liquid Biopsies

  2023cites this paper
• Early Detection of Ovarian Cancer.

  2023cites this paper
• MS-Based Proteomics of Body Fluids: The End of the Beginning

  2023cites this paper
• Top–Down Proteomics of Human Saliva, Analyzed with Logistic Regression and Machine Learning Methods, Reveal Molecular Signatures of Ovarian Cancer

  2023cites this paper
• Musculoskeletal Biomarkers Response to Exercise in Older Adults

  2022cites this paper
• Elevated Cardiac Troponin to Detect Acute Cellular Rejection After Cardiac Transplantation: A Systematic Review and Meta-Analysis

  2022cites this paper
• Flexible diagnostic measures and new cut‐point selection methods under multiple ordered classes

  2021cites this paper
• Racial/ethnic differences in average CA125 and CA15.3 values and its correlates among postmenopausal women in the USA

  2021cites this paper
• Circulating Cancer Biomarkers

  2021cites this paper
• [ENTPD5 gene is highly expressed in epithelial ovarian cancer: analysis based on Oncomine database and bioinformatics].

  2021cites this paper
• Human disease biomarker panels through systems biology

  2021cites this paper
• Identifying novel ovarian tumor biomarkers through mining of the transcriptome of circulating immune cells: A proof‐of‐concept study

  2021cites this paper
• A Convolutional Neural Network Approach for Detecting Malignancy of Ovarian Cancer

  2021cites this paper
• OCaMIR—A Noninvasive, Diagnostic Signature for Early-Stage Ovarian Cancer: A Multi-cohort Retrospective and Prospective Study

  2021cites this paper
• Detection of Plasma Circulating Tumor DNA in Ovarian Cancer and Its Clinical Significance

  2020cites this paper
• Magnetic bead-amplified voltammetric detection for carbohydrate antigen 125 with enzyme labels using aptamer-antigen-antibody sandwiched assay

  2020cites this paper
• Potential biomarkers for predicting of depression in diabetes mellitus

  2020cites this paper
• Gynecological Cancers Caused by Deficient Mismatch Repair and Microsatellite Instability

  2020cites this paper
• Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in Cancer

  2020cites this paper
• Issues and solutions in biomarker evaluation when subclasses are involved under binary classification

  2020cites this paper
• Circulating long non-coding RNA GAS5 (growth arrest-specific transcript 5) as a complement marker for the detection of malignant mesothelioma using liquid biopsies

  2020cites this paper
• A comprehensive and comparative review of optimal cut-points selection methods for diseases with multiple ordinal stages

  2019cites this paper
• Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary

  2019cites this paper
• Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel

  2019cites this paper
• A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer*

  2019cites this paper
• Biomarkers of Gynecological Cancers

  2019cites this paper
• Receiver Operating Characteristic Analysis Under Extended Tree or Umbrella Ordering

  2019cites this paper
• Another Round of “Clue” to Uncover the Mystery of Complex Traits

  2018cites this paper
• Exploring prognostic genes in ovarian cancer stage-related coexpression network modules

  2018cites this paper
• [Early detection and treatment of breast cancer].

  2018cites this paper
• Multiplexed Autoantibody Signature for Serological Detection of Canine Mammary Tumours

  2018cites this paper
• CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer

  2018cites this paper
• Trends in Cancer Antigen 125 testing 2003‐2014: A primary care population‐based cohort study using laboratory data

  2018cites this paper
• Improving the Clinical Validity of Biomarker Research in Cancer Detection

  2017cites this paper
• Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages

  2017cites this paper
• Epidemiologic paradigms for progress in ovarian cancer research

  2017cites this paper
• Molecular Biomarkers in Ovarian Carcinoma

  2017cites this paper
• Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer.

  2017cites this paper
• A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours

  2017cites this paper
• A combination of circulating miRNAs for the early detection of ovarian cancer

  2017cites this paper
• A multiplex platform for the identification of ovarian cancer biomarkers

  2017cites this paper
• Nano‐delivery system targeting to cancer stem cell cluster of differentiation biomarkers

  2017cites this paper
• Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer

  2017influential citation
• HIF‐1α binding to AEG‐1 promoter induced upregulated AEG‐1 expression associated with metastasis in ovarian cancer

  2017cites this paper
• EPIC Early Detection of Ovarian Cancer

  2016cites this paper
• A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort

  2016cites this paper
• Novel risk models for early detection and screening of ovarian cancer

  2016cites this paper
• Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives.

  2016cites this paper
• Protein Z: A putative novel biomarker for early detection of ovarian cancer

  2016cites this paper
• Autoantibodies against tumor-associated antigens in the early detection of lung cancer.

  2016cites this paper
• An emerging micro-scale immuno-analytical diagnostic tool to see the unseen. Holding promise for precision medicine and P4 medicine.

  2016cites this paper
• Electrochemistry-based approaches to low cost, high sensitivity, automated, multiplexed protein immunoassays for cancer diagnostics.

  2016cites this paper
• Early Detection of Ovarian Cancer EPIC Early Detection of Ovarian Cancer

  2016cites this paper
• Screening to improve ovarian cancer prognosis?

  2016cites this paper
• Detection of glyco‐mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours

  2015cites this paper
• Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.

  2015cites this paper
• Microchip ELISA coupled with cell phone to detect ovarian cancer HE4 biomarker in urine.

  2015cites this paper
• Tumormarkerforschung für die klinische Praxis

  2015cites this paper
• Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis

  2015cites this paper
• Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry

  2015cites this paper
• Epidemiologic design and analysis for proteomic studies: a primer on -omic technologies.

  2015cites this paper
• Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening

  2015cites this paper
• The abnormal express of E-cadherin and β-catenin in tissue and significance of CA153, TSGF, CA125 and CEA for detection and in judging the prognosis of breast cancer

  2015cites this paper
• Identifying post-menopausal women at elevated risk for epithelial ovarian cancer.

  2015cites this paper
• The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource.

  2015cites this paper
• Immunohistochemistry applications in breast carcinoma: The Hypoxia Inducible Factor 1a, Estrogen Receptor, Progesterone Receptor and HER2 expression before and after neoadjuvant chemotherapy

  2015cites this paper
• Early Detection and Treatment of Breast Cancer by Random Peptide Array in neuN Transgenic Mouse Model

  2015cites this paper
• Clinical presentation and diagnostics

  2015cites this paper
• Validation of new cancer biomarkers: a position statement from the European group on tumor markers.

  2015cites this paper
• Biomarker research with prospective study designs for the early detection of cancer.

  2014cites this paper
• In 2014, can we do better than CA125 in the early detection of ovarian cancer?

  2014cites this paper
• Laboratory Detective Work Identifies a Mishandling Problem in Sample Aliquoting

  2014cites this paper
• Nipple Discharge of CA15-3, CA125, CEA and TSGF as a New Biomarker Panel for Breast Cancer

  2014cites this paper
• Epigenetic biomarkers in epithelial ovarian cancer.

  2014cites this paper
• Array-based sensing using nanoparticles: an alternative approach for cancer diagnostics.

  2014cites this paper
• As if biomarker discovery isn't hard enough: the consequences of poorly characterized reagents.

  2014cites this paper
• Can CA-125 Predict Lymph Node Metastasis in Epithelial Ovarian Cancers in Turkish Population?

  2014cites this paper
• Ovarian Cancer Screening and Early Detection

  2014cites this paper
• MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

  2014cites this paper
• Gold nanorods combine photoacoustic and Raman imaging for detection and treatment of ovarian cancer

  2014cites this paper
• Enhancement of MS Signal Processing For Improved Cancer Biomarker Discovery

  2014cites this paper
• Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.

  2014cites this paper
• Early Biomarkers in Breast Cancer

  2014cites this paper
• Biomarkers in pharmacology and drug discovery.

  2014cites this paper
• Applications of blood-based protein biomarker strategies in the study of psychiatric disorders.

  2014cites this paper
• Control values of ovarian cancer tumor markers and standardisation of a protocol for sampling peritoneal fluid and performing washing during laparoscopy

  2014cites this paper
• The Impact of Chromosomal Aberrations on the Regulation of Kallikrein 6 Expression in Serous Ovarian Carcinoma

  2013cites this paper